B. Planz et al., Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor, PROSTATE, 41(4), 1999, pp. 233-242
BACKGROUND. Growth and development of the prostate are androgen-dependent.
Keratinocyte growth factor (KGF), widely expressed by mesenchymal cells, is
thought to act like an andromedin between stroma and epithelium of the pro
state. Since KGF has recently emerged as an autocrine mediator in prostate
cancer, we investigated the role KGF plays in the human prostate and its re
lationship to androgen receptor (AR).
METHODS. Normal (n = 13), benign hyperplastic (n = 5), and neoplastic (n =
14) human prostate tissues as well as cultured epithelial and stromal cells
were analyzed using polymerase chain reaction (PCR), Western blot analysis
, and immunohistochemistry.
RESULTS. Reverse transcriptase polymerase chain reaction and Western blotti
ng showed KGF expression in stromal cultured cells of the normal prostate b
ut not in epithelial cells. Using immunohistochemistry, KGF was found to be
Localized in fibroblasts and smooth muscle cells, independent of prostate
disease. There was KGF expression in epithelial cells of BPH and prostate c
ancer. Human androgen receptor was uniformly expressed in the same secretor
y glandular cells that were positive for KGF in BPH and prostate cancer.
CONCLUSIONS. Our results provide evidence that KGF is a stromal-derived med
iator, recently shown to act in a paracrine manner in normal prostate but n
ow detected in epithelial cells in prostate cancer and BPH. These findings
support the hypothesis that KGF might act as an autocrine factor in prostat
e cancer and BPH. (C) 1999 Wiley-Liss, Inc.